Interim report
Page 1
Ref. No.: WOCK/SEC/SE/2026-27/045 2nd November, 2026 BSE Limited Corporate Relations Department P J Towers Dalal Street Mumbai - 400 001 Scrip Code: 532300 National Stock Exchange of India Limited Exchange Plaza Bandra Kurla Complex Bandra (E) Mumbai - 400 051 NSE Symbol: WOCKPHARMA Dear Sir/Madam, Subject: Outcome of the Board Meeting Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations’); and in continuation to our letter bearing reference no: WOCK/SEC/SE/2026-27/042 dated 27th October, 2026, we wish to inform you that the Board of Directors of the Company, at its meeting held today i.e. 2nd November, 2026, inter- alia, has approved the Un-Audited Financial Results (Standalone & Consolidated) for the quarter and half year ended 30th September, 2026; Pursuant to Regulations 30 and 33 read with Schedule III of the Listing Regulations, we enclose herewith the Un-Audited Financial Results (Standalone & Consolidated) for the quarter and half year ended 30th September, 2026 along with the Limited Review Report issued by MSKC & Associates , LLP, Statutory Auditors of the Company on the same (enclosed as Annexure I). The meeting of the Board of Directors commenced at 12:05 p.m. and concluded at 3:45 p.m. Kindly take the same on record. Thanking you, For Wockhardt Limited Rashmi Mamtura Company Secretary Encl: as above
Page 2
MSKC & Associates LLP Chartered Accountants 602, Floor 6, Raheja Titanium Western Express Highway, Geetanjali Railway Colony Ram Nagar, Goregaon (E) Mumbai 400063, INDIA Independent Auditor’s Review Report on Standalone unaudited financial results of Wockhardt Limited for the quarter and year to date ended September 30, 2026 pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. To The Board of Directors of Wockhardt Limited 1. We have reviewed the accompanying statement of standalone unaudited financial results of Wockhardt Limited (hereinafter referred to as ‘the Company’) for the quarter ended September 30, 2026 and the year to-date results for the period from April 01, 2026 to September 30, 2026 (‘the Statement’) attached herewith, being submitted by the Company pursuant to the requirements of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (‘the Regulations’). 2. This Statement, which is the responsibility of the Company’s Management and has been approved by the Company’s Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 ‘Interim Financial Reporting’, prescribed under Section 133 of the Companies Act, 2013 (‘the Act’) read with relevant rules issued thereunder (‘Ind AS 34’) and other recognised accounting principles generally accepted in India and is in compliance with the Regulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, “Review of Interim Financial Information Performed by the Independent Auditor of the Entity” issued by the Institute of Chartered Accountants of India. A review of interim financial infuimalion consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under section 143(10) of the Act and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4. Based on our review conducted as stated in paragraph 3 above, nothing has come to our attention that causes us to believe that the accompanying Statement prepared in accordance with the recognition and measurement principles laid down in Ind AS 34 and other recognised accounting principles generally accepted in India has not disclosed the infoiination required to be disclosed in terms of the Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. For M S K C & Associates LLP Chartered Accountants ICAI Firm Registration Number: 001595S/S000168 7 2 | - - i _ d Bhavik L. Shah Partner Membership No.: 122071 UDIN: 26122071LHPEWC8288 Place: Mumbai Date: November 02, 2026 Registered Office: 10Lh Floor, Level 13th, Module A , 21/22, Olympia Cyberspace, Alandur Road, Arulaiyammanpet, Guindy, Chennai 600032, Tamil Nadu, India Tel: +91 44 6131 0200 | LLPIN: ACK-7004 Ahmedabad | Bengaluru I Chennai | Gurugram | Hyderabad | Kolkata | Pune
Page 3
WOCKHARDT LIMITED Registered Office: D-4 MIDC, Chikalthana, Chhatrapati Sambhaji Nagar - 431 006 Global Headquarters: Wockhardt Towers, Bandra Kurla Complex, Bandra (East), Mumbai 400 051 CIN:L24230MH 1999PLC120720 Tel: 91 22 2653 4444 ; Fax: 91 22 2652 3905; e-mail id : investorrelations@wockhardt.com; Website: www.wockhardt.com STATEMENT OF STANDALONE UNAUDITED RESULTS FOR THE QUARTER AND SIX MONT HS ENDED SEPTEMBER 30. 2026 {Rs in Crore except per share data) PARTICULARS 3 MONTHS 3 MONTHS 3 MONTHS 6 MONTHS 6 MONTHS YEAR ENDED ENDED ENDED ENDED ENDED ENDED 30/09/2026 30/06/2026 30/09/2025 30/09/2026 30/09/2025 31/03/2026 (Refer notes below) Unaudited Unaudited Unaudited Unaudited Unaudited Audited I Income (a) Revenue from operations 580 561 380 1,141 793 1,739 (b) Other income 21 33 30 54 55 137 Total income 601 594 410 1,195 848 1,876 2 Expenses (a) Cost of materials consumed 135 106 75 241 149 309 (b) Purchase of stock-in-trade 54 57 51 111 90 198 (c) Changes in inventories of finished goods, stock-in- trade and work-in-progress (47) 0.08 (55) (47) (55) (92) (d) Employee benefits expense 96 85 88 181 156 313 (e) Finance costs 48 43 44 91 85 176 (f) Depreciation and amortisation expense 47 41 45 88 91 186 (g) Other expenses 168 155 108 323 209 494 Total expenses 501 487 356 988 725 1,584 3 Profit before exceptional items and tax fl-2f 100 107 54 207 123 292 4 Exceptional items- credit - - - - - 25 5 Profit before tax (3 ± 4t 100 107 54 207 123 317 6 Tax expense: Current tax Deferred tax - - - - - - 7 Net Profit after tax (5 ± 6) 100 107 54 207 123 317 8 Other Comprehensive Income: i) Items that will not be reclassified to Profit or Loss - credit/fcharge) (consisting of re-measurement of net defined benefit liability) 0.08 0.08 (0.22) 0.16 (0.45) 0.08 ii) Income tax relating to items that will not be reclassified to Profit or Loss - - - - * iii) Other Comprehensive Income (net of tax) (8i ± 8ii) 0.08 0.08 (0.22) 0.16 (0.45) 0.08 9 Total Comprehensive Income (7 ± 8(iii)) 100 107 54 207 123 317 10 Paid-up equity share capital (face value ofRs. 5/- each) 81 81 81 81 81 81 11 Other Equity excluding Revaluation Reserves as per balance sheet 3,003 12 Earnings per share (face value of Rs. 5/- each) (♦not annualised) (a) Basic (Rs.) 6.15* 6.62* 3.26* 12.77* 7.51* 19.54 (b) Diluted (Rs.) 6.14* 6.61* 3.25* 12.75* 7.50* 19.52
Page 5
WOCKHARDT LIMITED Registered Office: D-4 MIDC, Chikalthana, Chhatrapati Sambhaji Nagar - 431 006 Global Headquarters: Wockhardt Towers, Bandra Kurla Complex, Bandra (East), Mumbai 400 051 STATEMENT OF STANDALONE ASSETS AND LIABILITIES (Rs. in Crore) PARTICULARS As at 30/09/2026 Unaudited As at 31/03/2026 Audited A) ASSETS 1 Non- Current assets (a) Property, plant and equipment 927 907 (b) Right of use assets 196 221 (c) Capital work-in-progress 105 121 (d) Intangible assets 578 224 (e ) Intangible assets under development 1,122 1,276 (f) Financial assets (i) Investments in subsidiaries 297 297 (ii) Other Investments * 0 0 * Rs. 0.45 crore (Previous year - Rs. 0.45 crore) (iii) Other non-current financial assets 58 73 (g) Deferred tax assets (Net) 250 250 (h) Non-current tax assets (Net) 79 78 (i) Other non-current assets 113 107 Sub-total- Non-current assets 3.725 3.5S-I 2 Current assets (n) Inventories 596 533 (b) Financial assets (i) Investments 117 412 (ii) Trade receivables 961 846 (iii) Cash and cash equivalents 148 76 (iv) Bank balances (other than Cash and cash equivalents) 232 31 (v) Other current financial assets 79 103 (c) Other current assets 296 289 Sub-total - Current assets 2,429 2,290 3 Assets held-for-sale 26 91 TOTAL ASSETS 6,180 5,935 B) EQUITY AND LIABILITIES 1 Equity (a) Equity share capital 81 81 (b) Other Equity 3,212 3,003 Sub-total- Equity 3,293 3,084 2 Liabilities I. Non- Current liabilities (a) Financial liabilities (i) Borrowings 1,177 1,244 (ii) Lease Liabilities 136 141 (b) Provisions 42 40 (c) Other non-current liabilities 2 * Sub-total- Non-current linbiliftts 1,3*7 1.42* II. Current liabilities (a) Financial liabilities (i) Borrowings 627 501 (ii) Lease Liabilities 52 78 (iii) Trade payables a. Total outstanding dues of micro enterprises and small enterprises 74 85 b Total outstanding dues of creditors other than micro enterprises and small enterprises 496 418 (iv) Other current financial liabilities 115 189 ’b) Other current liabilities 129 120 'c) Provisions 35 33 [d) Current tax liabilities (Net) 2 2 Sub-total- Current liabilities 1.530 1,426 J f + / * ''S jfN L Total Uiililllllej 2,887 2,851 j | 5 [ - ^ C jEJlI TOTAL EQUITY AND LIABILITIES -------------------i u A -------------------l u l -------------------------------------------------------------------- 6,180 *,935 FOR WOCKHARDT LIMITED Mumbai Date: November 02, 2026 K110 R A KIW A LA CHAIRMAN U1IN: UUU456U8
Page 6
WOCKHARDT LIMITED Registered Office: D-4 MIDC, Chikalthana, Chhatrapati Sambhaji Nagar - 431 006 Global Headquarters: Wockhardt Towers, Bandra Kurla Complex, Bandra (East), Mumbai 400 051 ■STANDALONE UNAUDITED CASH FLOW STATEMENT FOR SIX MONT HS ENDED SEPTEMBER 30. 2026 (Rs. in Crore) PARTICULARS 6 MONTHS 6 MONTHS ENDED ENDED 30/09/2026 30/09/2025 (Refer notes below) Unaudited Unaudited Cash flow from/(used in) Operating activities Profit before tax 207 123 Adjustments for: Depreciation and amortisation expense 88 91 Allowance for expected credit loss, doubtful advances and bad debts 2 7 Profit on sale of fixed assets (Net) (20) (14) Gain on sale of investments (20) (9) Finance costs 91 85 Foreign exchange fluctuation gain, net (10) (18) Interest income (6) (2) Employee share based payments expenses 3 1 Fair valuation impact on investments 8 (5) Operating profit before working capital changes 343 259 Movements in Working capital Increase in lnventori.es (63) (75) Increase in Trade receivables (100) (98) (IncreaseJ/Dccrease in Loans and Advances and other assets (17) 57 Increase/(Decrease) in Liabilities and provisions 17 (58) Increase/fDecrease) in Trade payables 63 (6) Cash generated from operations 243 79 Income tax paid (net) (1) (2) Net cash inflow from Operating activities 242 77 Cash flow from/(used in) Investing activities Purchase of property, plant and equipment and capital work-in progress (59) (62) Proceeds from sale of property, plant and equipment, including Asset held- for -sale OJ Guarantee commission received - 3 Final settlement proceeds of the holdback amount under Business transfer 22agreement Purchase of Intangible assets and Intangible assets under development (287) (100) Sale/(Purchase) of current investments (net) 308 (260) Margin money under lien and Bank balances (other than cash and cash equivalents) (184) 25 Interest received 2 1 Net cash outflow from Investing activities (113) (379) Cash flow from/(used in) Financing activities Transaction cost related to Right Issue/QIP concluded during earlier years - (1) Proceeds from Issuance of Equity share capital under ESOS* - 0 [* Previous period- Rs. 0.003 crore] Proceeds from Long-term buuuwings 109 550 Repayment of Long term borrowings (75) (80) Short-term borrowings (net) 102 (9) Loans from Related parties- Long term 80 12 Repayment of loans taken from Related parties- Long term (156) (32) Repayment of Lease liabilities ( refer note 2 below) (41) (39) Finance costs paid (76) (75) Net cash (outflowVinflow from Financing activities (57) 326 Net Increase in Cash and Cash equivalents 72 24 Cash and cash equivalents as at the beginning of the period 76 35 Cash and cash equivalents as at the end of the period 148 59
Page 7
:2 : Reconciliation of cash and cash equivalents as per the cash flow stntcmcnt: (Rs. in Croce) As at As at 30/09/2026 30/09/2025 Cash and cash equivalents as per above comprise of the following: Balance with banks: - in current account 148 57 - deposits with maturity of less than 3 months - 2 Balance as per the Statement of cash flows 148 59 Notes: 1. The above statement of cash flows has been prepared under the indirect method as set out in Ind AS 7 'Statement of Cash Flows'. 2. Repayment of lease liabilities consists of: Payment of interest Rs. 9 crore (Previous period - Rs. 12 crore) Payment of Principal Rs. 32 crore (Previous period - Rs. 27 crore) 3. Figures in bracket indicate cash outflow. Mumbai Date: November 02,2026 FOR WOCKHARDT LIMITED S X I S KHORAKIWALA CHAIRMAN DIN: 00045608
Page 8
MSKC & Associates LLP Chartered Accountants 602, Floor 6, Raheja Titanium Western Express Highway, Geetanjali Railway Colony Ram Nagar, Goregaon (E) Mumbai 400063, INDIA Independent Auditor’s Review Report on consolidated unaudited financial results of Wockhardt Limited for the quarter ended and year to date September 30, 2026 pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended To the Board of Directors of Wockhardt Limited 1. We have reviewed the accompanying Statement of consolidated unaudited financial results of Wockhardt Limited (hereinafter referred to as ‘the Holding Company’) which includes its subsidiaries, (the Holding Company and its subsidiaries together referred to as the ‘Group’) for the quarter ended September 30, 2026 and the year to-date results for the period from April 01, 2026 to September 30, 2026 (‘the Statement’) attached herewith, being submitted by the Holding Company pursuant to the requirements of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (‘the Regulations’). 2. This Statement, which is the responsibility of the Holding Company’s Management and approved by the Holding Company’s Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 ‘Interim Financial Reporting’ prescribed under Section 133 of the Companies Act, 2013 (‘the Act’) read with relevant rules issued thereunder (‘Ind AS 34’) and other recognised accounting principles generally accepted in India and is in compliance with the Regulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, ‘Review of Interim Financial Information Performed by the Independent Auditor of the Entity’ issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under section 143(10) of the Act and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. We also performed procedures in accordance with the circular issued by the Securities and Exchange Board of India under Regulation 33 (8) of the Regulations, to the extent applicable. 4. This Statement includes the results of the Holding Company and the following entities: Sr. No Name of the Entity Relationship with the Holding Company 1 Wockhardt UK Holdings Limited Wholly Owned Subsidiary 2 CP Pharmaceuticals Limited Step-Down Subsidiary 3 CP Pharma (Schweiz) AG Step-Down Subsidiary 4 Wallis Group Limited Step-Down Subsidiary 5 The Wallis Laboratory Limited Step-Down Subsidiary Office: 10lh Floor, Level 13lh, Module 4, 21/22, Olympia Cyberspace, Alandur Road, Arulaiyammanpet, Guindy, Chennai 600032, Tamil Nadu, India Tel: +91 44 6131 0200 | LLPIN: ACK-7004 Ahmedabad | Bengaluru | Chennai | Gurugram | Hyderabad | Kolkata | Pune
Page 9
MSKC St Associates LLP Chartered Accountants 6 Wockhardt Farmaceutica Do Brasil Ltda Step-Down Subsidiary 7 Wallis Licensing Limited Step-Down Subsidiary 8 Wockhardt Infrastructure Development Limited Wholly Owned Subsidiary 9 Z&Z Services GmbH Step-Down Subsidiary 10 Wockhardt Europe Limited Wholly Owned Subsidiary 11 Wockhardt Nigeria Limited Step-Down Subsidiary 12 Wockhardt UK Limited Step-Down Subsidiary 13 Wockpharma Ireland Limited Step-Down Subsidiary 14 Pinewood Laboratories Limited Step-Down Subsidiary 15 Pinewood Healthcare Limited Step-Down Subsidiary 16 Wockhardt Holding Corp. Step-Down Subsidiary 17 MGP Inc. Step-Down Subsidiary 18 Wockhardt Farmaceutica SA DE CV Step-Down Subsidiary 19 Wockhardt Services SA DE CV Step-Down Subsidiary 20 Wockhardt Bio AG Subsidiary 21 Wockhardt Bio (R) LLC Step-Down Subsidiary 22 Wockhardt Bio Pty Limited Step-Down Subsidiary 23 Wockhardt Medicines Limited Wholly Owned Subsidiary 24 Wockhardt Bioscience Limited (Formerly, Wockhardt Bionova Limited) Wholly Owned Subsidiary 25 Wockhardt Antibiotics (Ireland) Limited Step-Down Subsidiary 26 Wockhardt Suisse AG Step-Down Subsidiary 27 Wockhardt Suisse USA Holding Corporation Step-Down Subsidiary 28 Wockhardt Suisse USA LLC Step-Down Subsidiary 5. Based on our review conducted and procedures performed as stated in paragraph 3 above and based on the consideration of the review reports of the other auditors referred to in paragraph 6 below, nothing has come to our attention that causes us to believe that the accompanying Statement prepared in accordance with the recognition and measurement principles laid down in Ind AS 34 and other recognised accounting principles generally accepted in India has not disclosed the information lered Office: 10ll> Floor, Level 13"', Module 4, 21/22, Olympia Cyberspace, Alandur Road, Arulaiyammanpet, Guindy, Chennai 600032, Tamil Nadu, India Tel: +91 44 6131 0200 | LLPIN: ACK-7004 Ahmcdabad | Bengaluru | Chennai | Gurugiaui | Hyderabad | Kolkata | Mumbai I Pune
Page 10
MSKC & Associates LLP Chartered Accountants required to be disclosed in terms of the Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. 6. We did not review the interim financial information of 5 subsidiaries included in the Statement, whose interim financial information (before consolidation adjustment) reflects total assets of Rs. 6923 crores as at September 30, 2026, total revenues of Rs. 836 crores and Rs.1612 crores, total net profit after tax of Rs.30 crores and Rs. 28 crores and total comprehensive income of Rs. 30 crores and Rs.28 crores, for the quarter ended September 30, 2026 and for the period from April 01, 2026 to September 30, 2026, respectively, and cash flows (net) of Rs. (6) crores for the period from April 01, 2026 to September 30, 2026, as considered in the Statement. These interim financial statements have been reviewed by other auditors whose reports have been furnished to us by the Management and our conclusion on the Statement, in so far as it relates to the amounts and disclosures included in respect of these subsidiaries, is based solely on the report of the other auditors and the procedures performed by us as stated in paragraph 3 above. Our conclusion is not modified in respect of the above matter with respect to our reliance on the work done by and report of the other auditors. 7. The Statement includes the interim financial information of 18 subsidiaries which have not been reviewed by their auditors, whose interim financial information (before consolidation adjustment) reflects total assets of Rs. 489 crores as at September 30, 2026, total revenue of Rs. 44 crores and Rs. 90 crores, total net profit after tax of Rs. 4 crores and Rs.14 crores and total comprehensive income of Rs. 4 crores and Rs. 14 crores for the quarter ended September 30, 2026 and for the period from April 01, 2026 to September 30, 2026 respectively, and cash flows (net) of Rs. 18 crores for the period from April 01, 2026 to September 30, 2026, as considered in the Statement. These interim financial information have been furnished to us by the Management and our conclusion on the Statement in so far as it relates to the amounts and disclosures included in respect of these subsidiaries is based solely on such management prepared unaudited interim financial information. According to the information and explanations given to us by the Management, these interim financial information are not material to the Group. Our conclusion is not modified in respect of the above matter with respect to our reliance on the financial result certified by the management. For M S K C & Associates LLP Chartered Accountants ICAI Firm Registration Number: 001595S/S000168 Membership No.: 122071 UDIN: 26122071VHAQKM2967 Place: Mumbai Date : November 02, 2026 Registered Office: 10lh Floor, Level 13% Module 4, 21/22, Olympia Cyberspace, Alandur Road, Arulaiyammanpet, Guindy, Chennai 600032, Tamil Nadu, India Tel: +91 44 6131 0200 | LLPIN: ACK-7004 Ahmedabsd | Oengalum | ClieuiMi | Gunii’taiu | Hyi.letabad | Kolkata | Mumbai | Pune
Page 11
WOCKHARDT LIMITED Registered Office; D-4 MIDC, Chikalthana, Chhatrapatl Sambhajl Nagar- 431 006 Global Headquarters; Wockhardt Towers, Bandra Kurla Complex, Bandra (East), Mumbai 400 051 CIN: L24230MH1999PLC120720 Tel: 9122 2653 4444; Fax: 9122 2652 3905; e-mail id; investorrelations@wockhardt.com, Website: www.wockhardt.com {Rs. In Crore except per share data) STATEMENT OF CONSOLIDATED UNAUDITED RESULTS FOR THE QUARTER AND SIX MONTHS ENDED SEPTEMBER 30, 2026 3 MONTHS 3 MONTHS 3 MONTHS 6 MONTHS 6 MONTHS YEAR PARTICULARS ENDED ENDED ENDED ENDED ENDED ENDED 30/09/2026 30/06/2026 30/09/2025 30/09/2026 30/09/2025 31/03/2026 (Refer notes Below) Unaudited Unaudited Unaudited Unaudited Unaudited Audited Income (a) Revenue from operations 969 929 782 1,898 1,520 3,373 (b) Other Income 11 31 21 42 41 111 Total income 980 960 803 1,940 1,561 3,484 Expenses (a) Cost of materials consumed 243 233 159 476 327 674 (b) Purchase of stock-in-trade 123 109 129 232 269 586 (c) Changes In Inventories of finished goods, Stock-In-Trade and work-in-progress (25) (22) (55) (47) (99) (128) (d) Employee benefits expense 201 203 186 404 357 725 (e) Finance costs 56 52 55 108 103 213 (f) Depreciation and amortisation expense 55 55 53 110 109 227 (g) Exchange fluctuation loss, net (9) (4) (18) (13) 11 (22) (h) Other expenses 263 218 203 481 405 886 Total expenses 907 844 712 1,751 1,482 3,161 3 Profit /(Loss) before exceptional Items and tax (1-2) 73 116 91 189 79 323 4 Exceptional items-charge - - - - (97) (851 5 Profit /(Loss) after exceptional Items and before tax (3 ± 4) 73 116 91 189 (18) 238 Tax expense: 6 Current tax - charge 4 7 3 11 7 18 Deferred tax - charge/ (credit) - (Net) (4) 2 6 (2) 1 21 7 Net Profit / (Loss) after tax (5 ± 6) 73 107 82 180 (26) 199 Attributable to : Equity shareholders of the Company 79 106 78 185 (12) 213 Non - Controlling Interest (6) 1 4 (5) (14) (14) 8 Other Comprehensive Income (a) Items that will not be reclassified to Profit or Loss - (charge)/ credit (consisting of re-measurement of net defined benefit (liability) / asset) 0.08 0.08 (0.22) 0.16 (0.45) 70 (b) Income tax relating to items that will not be reclassified to Profit or Loss - credlt/(charge) - - - (c) Items that will be reclassified to Profit or Loss - (charge)/ credit (Consisting of Exchange differences on translating the financial statements of foreign operations) 26 14 93 40 241 349 (d) Other Comprehensive Income (net of tax) (a ± b ± c) 26 14 93 40 241 419 < 1 Total Comprehensive Income (718 (d)> 99 121 173 220 215 618 Other Comprehensive Income attributable to : Equity shareholders of the Company 19 10 85 29 224 368 Non - Controlling Interest 7 4 8 11 17 51 26 14 93 40 241 419 Total Comprehensive Income attributable to : Equity shareholders of the Company 98 116 163 214 212 581 Non - Controlling Interest 1 5 12 6 3 37 99 121 175 220 215 618 10 Paid-up equity share capital (face value of Rs. 5/- each) 81 81 81 81 81 81 11 Other Equity excluding Revaluation Reserves as per Balance Sheet 4,059 12 Earnings per equity share (face value of Rs. 5/- each) [*not annualised) |a) Basic (Rs.) 4.85* 6.55* 4.81* 11.41* (0.72)* 13.12 'b) Diluted (Rs.) 4.85* 6.55* 4.81* 11.39* (0.72)* 13.10
Page 12
Notes To Consolidated Results:- The results were reviewed by the Audit Committee and approved by the Board of Directors at their meetings held on November 02, 2026. The results have been subjected to limited review by the Statutory Auditors of the Company. The Consolidated Results relate to Wockhardt Limited ('the Company' or 'the Holding Company') and its Subsidiaries (together constitute 'the Group’) and are prepared by applying Ind AS 110- "Consolidated Financial Statements". 3) Key Financials on Standalone basis: (Rs. In Crore) PARTICULARS 3 MONTHS ENDED 30/09/2026 3 MONTHS ENDED 30/06/2026 3 MONTHS ENDED 30/09/2025 6 MONTHS ENDED 30/09/2026 6 MONTHS ENDED 30/09/2025 YEAR ENDED 31/03/2026 Unaudited Unaudited Unaudited Unaudited Unaudited Audited Total Income 601 594 410 1,195 848 1,876 Profit (Loss) before tax 100 107 54 207 123 317 Profit (Loss) aftertax 100 107 54 207 123 317 Note: The unaudited standalone results have been filed with the Stock Exchanges under Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and are available on the Stock Exchanges websites (www.nselndia.com and www.bseindia.com) and also on the Company's website www.wockhardt.com. 5) The Group is exclusively into Pharmaceutical business segment. 6) For List of Subsidiaries as on September 30, 2026 please refer Annexure.
Page 13
WOCKHARDT LIMITED Registered Office: D-4 MIDC, Chikalthana, Chhatrapati Sambhajl Nagar -431 006 Global Headquarters: WockhardtTowers, flardra Kurla Complex, Bandra (East), Mumbai 400 051 STATEMENT OF CONSOLIDATED ASSETS AND LIABILITIES (Rs. In Crore) PARTICULARS As at 30/09/2026 As at 31/03/2026 Unaudited Audited A| ASSETS 1 Non- Current assets (a) Property, Plant and Equipment 1,317 1,314 (b) Right of use assets 284 304 (c) Capital work-in-progress 676 671 (d) Goodwill 1,040 1,028 (e) Other Intangible assets 271 145 (f] Intangible assets under development (g) Financial assets 1,743 1,708 (i) Investments 0 0 Rs. 0.45 crore (Previous year - Rs. 0.45 crore) (11) Other non- current Financial assets 56 72 (h) Deferred tax assets (Net) 48U 4// (1) Non-current tax assets (Net) 65 85 (J) Other non-current assets 160 114 1 Sub-total - Non-current assets 6,112 5,918 2 Current assets (a) Inventories 973 887 (b) Financial asseb (1) Investments 117 412 (i) Trade receivables 632 588 (fi) Cash and cash equivalents 330 217 (III) Dank balance (otliei than Cxkh and utli uqulvdluiilc) 2JJ 33 M Other current Financial assets 33 51 [cj Other current assets 446 410 Sub-total - Current assets 2,764 2,606 3 Assets held-for-sale 2b 91 TOTAL ASSETS 6,902 8,615 B) EQUITY AND LIABILITIES 1 Equity (a) Equity chare capital 81 81 (to) Other Equity 5,077 4,859 Equity attributable to the share holders of the Company 5,158 4,940 (cj: Non - Controlling Interest 342 341 Sub-total- Equity 5,500 5,281 2 Liabilities Non- Current liabilities (a) Financial liabilities 1) Buiiuwlngv 1,431 1,518 II) Lease Liabilities 42 38 III) Other non-current financial liabilities - 15 (b) Provisions 42 40 [e) Deferred tax liabilities (Net) 38 37 |d| Non-current liability - Others 64 64 Sub-total- Non-current liabilities 1.617 1.712 II. Current liabilities |a) Financial liabilities (i) Borrowings 719 607 (ii) Lease Liabilities (ill) Trade payables 46 70 Total outstanding dues of micro enterprises and small enterprises 74 85 Total outstanding dues of creditors other than micro enterprises and small enterprises 549 478 (iv) Other current financial liabilities 189 209 b) Other current liabilities 166 133 c) Provisions | 36 34 d) Current tax liabilities (Net) 6 6 Sub-total- Current liabilities 1,785 1.622 Total Liabilities 3,402 3.334 TOTAL EQUITY AND LIABILITIES 8,902 8.615 FOR WOCKHARDT LIMITED > 5 v n Mumbai \\ . ^ * i W f t Date: November 02, 2026 H F KHORAKIWALA CHAIRMAN DIN:00045G00
Page 14
WOCKHARDT UMITED Registered Office: D-4 MIDC, Chikalthana, Chhatrapati Sambhaji Nagar-431 006 Global Headquarters: Wockhardt Towers, Bandra Kurla Complex, Bandra (East), Mumbai 400 051 CONSOLIDATED UNAUDITED CASH FLOW STATEMENT FOR SIX MONTHS ENDED SEPTEMBER 30. 2026 (Rs in crorc) PARTICULARS 6 MONTHS ENDED 30/09/2026 6 MONTHS ENDED 30/09/2025 (Refer notes below) Unaudited Unaudited A CASH FLOWS FROM / (USED IN) OPERATING ACTIVITIES: Profit/(loss) after exceptional items and before tax 189 (18) Adjustments for: Exceptional items - Impact of Deconsolidation including impairment of Investment/Receivables 97 Depredation and amortization expense 110 109 Allowance/(Reversal of allowance) for expected credit loss, doubtful advance and Bad debts (3) 7 (Profit)/Loss on sale of fixed assets (Net) (20) (14) Gain on sale of investments (20) (9) Finance costs 108 103 Unrealised Foreign exchange loss/ (gain), net 1 15 Interest income (6) (2) Employee share based payments expenses 3 - Liabilities no longer required written back - (2) Fair valuation impact on investments 8 (5) Operating profit before working capita! changes 370 281 Movements In Working capital Increase In Inventories (78) (109) (Increase) / Decrease in trade receivables (37) 52 (Increase) / Decrease in Loans and Advances and other assets (36) 45 Increase / (Decrease) in Liabilities and provisions 29 (68) Cash generated from operations 248 201 income tax paid (net) (Hi (12) Net cash inflow from Operating activities (A) 237 189 B CASH FLOWS FROM / (USED IN) INVESTING ACTIVITIES: Purchase of Property, Plant and Equipment and Capital work-in progress (S3) (70) Purchase of Intangible assets and Addition In Intangible assets under development (155) (127) Proceeds from sale of property, plant and equipment (including asset held for sale) 85 14 Final settlement proceeds of the holdback amount under Business transfer agreement 22 - Margin money under lien and Bank balances (other than cash and cash equivalents) (184) 24 5ale/(Purchase) of Investments (net) 307 (260) Interest received 6 2 Net cash (outflow) from Investing activities (B) (2) (417) c CASH FLOWS FROM / (USED IN) FINANCING ACTIVITIES Transaction cost related to Right Issue/QIP concluded during earlier years 1 Proceeds from Issuance of Equity share capital under ESOS* . 0 [ * Previous period- Rs. 0:003 crore] Proceeds of long-term borrowings 109 550 Repayment of long-term borrowings (101) (91) Short-term borrowings (net) 85 (12) Loans from related parties- Long term 80 12 Repayment of loans taken from related parties- Long term (156) (32) Repayment of loans taken from related parties- Short term - - Repayment of Lease liabilities (Refer note 2 below) (38) (35) Finance costs paid (102) (96) Net cash inflow / (outflow) from Financing activities (C) (123) 297
Page 15
WOCKHARDT LIMITED Registered Office: D-4 MIDC, Chikalthana, Chhatrapati Sambhaji Nagar-431006 Global Headquarters: Wockhardt Towers, Bandra Kurla Complex, Bandra (East), Mumbai 400 051 CONSOLIDATED UNAUDITED CASH FLOW STATEMENT FOR SIX MONTHS ENDED SEPTEMBER 30, 2026 (Rsin crore) 6 MONTHS 6 MONTHS PARTICULARS ENDED ENDED 30/09/2026 30/09/2025 (Refer notes below) Unaudited Unaudited NET (DECREASE) / INCREASE IN CASH AND CASH EQUIVALENTS (A+B+C) 112 69 Cash and cash equivalents as at the beginning of the period 217 112 Exchange difference on translation of foreign cash and cash equivalent i - Impact of Deconsolidation - (4) Cash and cash equivalents as at the end of the period 330 177 Reconciliation of cash and cash equivalents as per the cash flow statement Cash and cash equivalents as per above comprise of the following Balance with banks: -in current accounts 330 177 330 177 Notes: 1. The above statement of cash flows has been prepared under the Indirect method as set out in Ind AS 7 'Statement of Cash Flows' 2. Repayment of lease liabilities consists of: Payment of Interest * A crore (Previous year: K 6 cruris) Payment of Principal * 34 crore (Previous year: * 29 crore)
Page 16
n «HL, im.jnum.mn'anty. f — wfcV '*V— ' U fi ii* Ski Cm S J 't i e s s m WOCKHARDT LIMITED Registered Office: D-4 MIDC, Chikalthana, Chhatrapati Sambhaji Nagar - 431006 Global Headquarters: Wockhardt Towers, Bandra Kurla Complex, Bandra (East), Mumbai 400 051 List of Subsidiaries as on September 30,2026 1 Wockhardt UK Holdings Limited 2 CP Pharmaceuticals Limited 3 CP Pharma (Schweiz) AG 4 Wallis Group Limited 5 The Wallis Laboratory Limited 6 Wockhardt Farmaceutica Do Brasil Ltda 7 Wallis Licensing Limited 8 Wockhardt Infrastructure Development Limited 9 Z&ZServicesGmbH 10 Wockhardt Europe Limited 11 Wockhardt Nigeria Limited 12 Wockhardt UK Limited 13 Wockpharma Ireland Limited 14 Pinewood Laboratories Limited 15 Pinewood Healthcare Limited 16 Wockhardt Holding Corp. 17 MGP Inc. 18 Wockhardt Farmaceutica SA DE CV 19 Wockhardt Services SA DE CV 20 Wockhardt Bio AG 21 Wockhardt Bio (R) LLC 22 Wockhardt Bio Pty Limited 23 Wockhardt Medicines Limited 24 Wockhardt Bioscience Limited (Formerly, Wockhardt Bionova Limited) 25 Wockhardt Antibiotics (Ireland) Limited 26 Wockhardt Suisse AG 27 Wockhardt Suisse USA Holding Corporation 28 Wockhardt Suisse USA LLC